Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Accumulated Depreciation (2019 - 2026)

Adagene (ADAG) posted quarterly Accumulated Depreciation of $7.8 million for Q4 2025, up 7.47% year-over-year from $7.3 million in Q4 2024, and up 3.87% quarter-over-quarter from $7.6 million in Q2 2025.

Analysis

Adagene (ADAG) Accumulated Depreciation (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Accumulated Depreciation for 7 consecutive years, with $7.8 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accumulated Depreciation rose 7.47% year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (up 7.47% YoY), while the FY2025 annual figure was $7.8 million, up 7.47% from the prior year.
  • Accumulated Depreciation climbed to $7.8 million in Q4 2025 per ADAG's latest filing, from $7.6 million in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $7.8 million in Q4 2025 and bottomed at $5.3 million in Q4 2021.
  • Historically, Accumulated Depreciation has averaged $6.8 million across 5 years, with a median of $7.1 million in 2024.
  • Annual changes were most pronounced in 2021 — Accumulated Depreciation advanced 24.05% — and 2025, when it increased 6.86%.
  • Adagene's Accumulated Depreciation stood at $5.3 million in 2021, then grew by 11.03% to $5.9 million in 2022, then climbed by 13.52% to $6.7 million in 2023, then climbed by 8.84% to $7.3 million in 2024, then increased by 7.47% to $7.8 million in 2025.
  • Business Quant data shows ADAG's Accumulated Depreciation at $7.8 million in Q4 2025, $7.6 million in Q2 2025, and $7.3 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.98 Mn
Dec 31, 2025 7.85 Mn
Jun 30, 2025 7.55 Mn
Dec 31, 2024 7.30 Mn
Jun 30, 2024 7.07 Mn
Dec 31, 2023 6.71 Mn
Dec 31, 2022 5.91 Mn
Dec 31, 2021 5.32 Mn
Dec 31, 2020 4.29 Mn
Dec 31, 2019 3.21 Mn